Evidence map›Paper›PMID 33371906›Full record

ArticleBMC medical genomics2020

Integrative analysis of histopathological images and chromatin accessibility data for estrogen receptor-positive breast cancer.

Siwen Xu, Zixiao Lu, Wei Shao, Christina Y Yu, Jill L Reiter, Qianjin Feng, Weixing Feng, Kun Huang, Yunlong Liu

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Siwen XuInstitute of Intelligent System and Bioinformatics, College of Automation, Harbin Engineering University, Harbin, Heilongjiang, China.ORCID 0000-0001-7936-0639
Zixiao LuGuangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, China.
Wei ShaoDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Christina Y YuDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Jill L ReiterDepartment of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
Qianjin FengGuangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, China.
Weixing FengInstitute of Intelligent System and Bioinformatics, College of Automation, Harbin Engineering University, Harbin, Heilongjiang, China. fengweixing@hrbeu.edu.cn.
Kun HuangDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. kunhuang@iu.edu.
Yunlong LiuCenter for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, USA. yunliu@iu.edu.
Indiana University School of MedicineHarbin Engineering University · CNSouthern Medical University · CNRegenstrief Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExisting studies have demonstrated that the integrative analysis of histopathological images and genomic data can be used to better understand the onset and progression of many diseases, as well as identify new diagnostic and prognostic biomarkers. However, since the development of pathological phenotypes are influenced by a variety of complex biological processes, complete understanding of the underlying gene regulatory mechanisms for the cell and tissue morphology is still a challenge. In this study, we explored the relationship between the chromatin accessibility changes and the epithelial tissue proportion in histopathological images of estrogen receptor (ER) positive breast cancer.

methodsAn established whole slide image processing pipeline based on deep learning was used to perform global segmentation of epithelial and stromal tissues. We then used canonical correlation analysis to detect the epithelial tissue proportion-associated regulatory regions. By integrating ATAC-seq data with matched RNA-seq data, we found the potential target genes that associated with these regulatory regions. Then we used these genes to perform the following pathway and survival analysis.

resultsUsing canonical correlation analysis, we detected 436 potential regulatory regions that exhibited significant correlation between quantitative chromatin accessibility changes and the epithelial tissue proportion in tumors from 54 patients (FDR < 0.05). We then found that these 436 regulatory regions were associated with 74 potential target genes. After functional enrichment analysis, we observed that these potential target genes were enriched in cancer-associated pathways. We further demonstrated that using the gene expression signals and the epithelial tissue proportion extracted from this integration framework could stratify patient prognoses more accurately, outperforming predictions based on only omics or image features.

conclusionThis integrative analysis is a useful strategy for identifying potential regulatory regions in the human genome that are associated with tumor tissue quantification. This study will enable efficient prioritization of genomic regulatory regions identified by ATAC-seq data for further studies to validate their causal regulatory function. Ultimately, identifying epithelial tissue proportion-associated regulatory regions will further our understanding of the underlying molecular mechanisms of disease and inform the development of potential therapeutic targets.

Indexed as

Gene Expression Regulation, NeoplasticAdultAgedAged, 80 and overBiomarkers, TumorBreast NeoplasmsChromatinComputational BiologyEstrogen Receptor alphaFemaleGene Expression ProfilingHumansMiddle AgedMolecular ImagingPrognosisPromoter Regions, GeneticBiomarkers, TumorChromatinESR1 protein, humanEstrogen Receptor alphaATAC-seqBioinformaticsChromatin accessibility dataComputational biologyHistopathological imagesIntegrative analysis

Identifiers

PMID33371906
PMCPMC7771206
OpenAlexW3117823408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.